External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared With Medical Chart Reviews
Bibliographic Data
| ID | 14338292 |
|---|---|
| Authors | Xianglin L Du (0000-0003-0119-5252, The University of Texas Health Science Center at Houston, corresponding author), Charles R Key (University of New Mexico), Lois Dickie (University of New Mexico), Ronald Darling (University of New Mexico), Jane M Geraci (The University of Texas MD Anderson Cancer Center), Dong Zhang (0000-0003-3786-2272, John Sealy Hospital) |
| Year | 2006 |
| Volume | 44 |
| Issue | 2 |
| Pages | 124-131 |
| Publication date | 2006-02-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | Medical Care (JOURNAL) |
| Journal identifiers | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Publisher | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/01.mlr.0000196978.34283.a6 |
| PMID | 16434911 |
| OpenAlex | W2000260368 |
| Language | EN |
| Citations received | 10 |
| References cited | 40 |
BACKGROUND: Although Medicare claims data have been increasingly used to examine the patterns and outcomes of cancer chemotherapy, their external validity has not been well studied. OBJECTIVES: We sought to validate Medicare claims for chemotherapy compared with medical chart reviews. PATIENTS AND METHODS: We completed medical chart reviews for 1228 women who were diagnosed with breast cancer at age 65 and older between 1993 and 1999 in New Mexico that were linked with Medicare claims data, achieving an estimated sensitivity of more than 90% and a 0.05 level of precision. RESULTS: Of the 150 subjects identified by Medicare claims as receiving chemotherapy within 6 months of diagnosis, 75% were confirmed by medical records as having received chemotherapy. Of the remaining 25% of cases without chart verification, (1) 33 cases had 7 or more claims for chemotherapy and also had specific chemotherapy drugs indicated in Medicare data, representing 22% (33/150) of all cases that received chemotherapy according to Medicare claims and (2) 4 cases had 1 to 6 claims for chemotherapy, representing 3% (4/150) of all cases with claims for chemotherapy. Of those 1078 subjects who did not receive chemotherapy according to Medicare claims, more than 99% were confirmed by chart reviews. Observed agreement on chemotherapy between Medicare claims and chart reviews was 94% and overall reliability (kappa) was 0.69 (95% confidence interval = 0.63-0.76). CONCLUSIONS: Of cases identified as receiving chemotherapy by Medicare claims, 97% had strong evidence and only 3% had weak evidence for receiving this therapy
Breast cancer · Cancer · Chart · Medical physics · MEDLINE · Political science · Statistics · Economic and Financial Impacts of Cancer · Global Cancer Incidence and Screening · Internal Medicine · Medication Adherence and Compliance · Medicine · Oncology
Tradeoffs of Using Administrative Claims and Medical Records to Identify the Use of Personalized Medicine for Patients With Breast Cancer
Sensitivity of Medicare Claims Data for Measuring Use of Standard Multiagent Chemotherapy Regimens
An Evaluation of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data
Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer
Comparison of Seer Treatment Data With Medicare Claims
Treatment Patterns for Prostate Cancer
Accuracy and Complexities of Using Automated Clinical Data for Capturing Chemotherapy Administrations
Measuring Clinically Significant Chemotherapy-Related Toxicities Using Medicare Claims From Cancer and Leukemia Group B (CALGB) Trial Participants
Intended Versus Inferred Management After PET For Cancer Restaging
Identifying Specific Chemotherapeutic Agents in Medicare Data
Studying Outcomes and Hospital Utilization in the Elderly
Accuracy of Medicare Claims Data for Estimation of Cancer Incidence and Resection Rates Among Elderly Americans
Utility of the Seer-Medicare Data to Identify Chemotherapy Use
Studying Radiation Therapy Using Seer-Medicare-Linked Data
Construct Validity of Medicare Chemotherapy Claims
Potential for Cancer Related Health Services Research Using a Linked Medicare-Tumor Registry Database
Referral of Breast Cancer Patients to Medical Oncologists After Initial Surgical Management
Perceived Barriers to VA Mental Health Care Among Upper Midwest American Indian Veterans
Using Medicare Claims for Outcomes Research
Measuring Complications of Cancer Treatment Using the Seer-Medicare Data
Agreement of Medicare Claims and Tumor Registry Data for Assessment of Cancer-Related Treatment
Accuracy and Completeness of Medicare Claims Data for Surgical Treatment of Breast Cancer
| Unique citing works | 10 |
|---|---|
| Citations per year | 0.56 |
| Citation span | 2008 - 2016 (9) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 7 |